Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16505427

J. Clin. Oncol. 2006 Mar 1 24 7 1079-89

Download in:

View as

General Info

PMID
16505427